Thursday, May 5, 2016

Pharma Price Abuses In The News

Stay informed and up-to-date on the abuses of Pharma pricing with our national coverage of stories form around the U.S... Pharma prices are a major driver of healthcare costs and endanger American patients lives with pricing strategies that make medicines unavailable because they are unaffordable.  Keep up with the growing news coverage of the struggle for fair prices for American patients:

Drug Companies Pony Up in Illegal Marketing Cases, But Critics Wonder if Penalties are Enough…If you make truck deliveries in the overcrowded downtown streets of a big city, parking tickets might simply be a cost of doing business…For top drug companies, critics say, there’s an equivalent expense — the billions of dollars paid out to settle criminal and civil charges of illegal marketing practices, Medicaid overcharges and kickbacks…Big Pharma has written more than $30 billion in checks in the last 10 years to resolve the government allegations, according to statistics compiled by the consumer watchdog group Public Citizen. Nine drug manufacturers each forked over at least $900 million from 2006 through 2015…(read more

Bill aimed to limit the pain of prescription drug prices for Ohioans… ABC6 is On Your Side, trying to get to the bottom of sky rocketing prescription drug prices…A Hilliard man reached out to us after the price of his medication went through the roof. Like many people, Larry Farrow takes a prescription medication for his health. A recent price change almost gave him a heart attack."In 2015, I ordered the drug and it was $80 plus a $100 deductible," he said…(read more)

Wyden introduces bill to cap drug costs under Medicare…Sen. Ron Wyden (Ore.), the top Democrat on the Senate Finance Committee, on Wednesday introduced a bill aimed at protecting seniors from high drug costs, an issue that has attracted growing scrutiny…Wyden’s measure would cap drug cost-sharing for Medicare enrollees so that seniors would not have to pay out of pocket costs above a roughly $7,500 cap…(read more)

While patients in Massachusetts await affordable doses of the blockbuster hepatitis C drug Sovaldi, Rep. Joseph Kennedy III has financially benefited from the success of the drug’s manufacturer, Gilead Sciences, according to public financial disclosures and campaign finance records...And he’s not the only lawmaker profiting from investments in a company that has drawn unwelcome attention for the sky-high price of a lifesaving medication it produces. Kennedy held the largest stake, but 23 other members of the House and Senate held stock in the company in 2014, the most recent year for which disclosure statements are available...(read more)

 Survey on Prescription Drugs: Insights of Patients over 50, What Can be done to reduce prescription drug costs…This AARP survey was fielded to better understand consumers’ prescription drug use and any struggles consumers face with regard to the cost of their prescription drugs…(read more)

No comments:

Post a Comment